Fundraising Fox
/Companies
Sign in

J3 Bioscience

Salt Lake City, US · Utah corporation

Find your way into J3 Bioscience

28 people in our graph share verified history with the J3 Bioscience team — schools, employers, funds. One of them is your warm intro.

Alice Zhengunlockedknows John Fair · together at Synovate Healthcare (overlapped)
×5knows the team · via Affinnova, Inc.
knows the team · via J3 Bioscience
×5knows the team · via Rider University

J3 Bio develops an FDA-cleared intravaginal ring platform called LivRing for delivering active and functional ingredients to address women's health needs across multiple conditions and life stages. The company targets the direct-to-consumer women's health market with clinically validated solutions designed for accessibility outside traditional medical channels.

BiotechDigital HealthDirect to ConsumerFemTechHealthtechMedical Devices

Founders & leadership

DL
DJ LeeChair, Co-Founder & Board Director
TS
Tim S. GlassettExecutive
JFJohn Fair
John FairExecutiveJohn Fair held commercial and strategy roles across life sciences companies, including Chief Business & Commercial Officer at Daré Bioscience where he negotiated partnerships with Bayer and Organon, COO at Evofem Biosciences where he built the commercial organization and supported financing rounds, and early work in healthcare analytics serving pharmaceutical customers. He currently serves as Executive Officer and Director at J3 Bioscience, leading commercialization strategy for the company's FDA-cleared intravaginal delivery platform.
RT
R. Tyler McCabeCSO & Co-Founder & Board Director

Board

SJ
Stath J. KarrasBoard director
KM
Keith MarmerBoard director
DJ
Duck Joo LeeBoard director
RN
Ron NielsenBoard director
SS
Stephanie SingerBoard director
TE
Troy E. MasonBoard director
SA
Sheryl A. KingsbergBoard director
JF
Jayne F. CarneyBoard director

Reported raises · per SEC filings

Form D private placements

$5.7M disclosed across 10 rounds · 2013–2023

▶$1.7MraisedAug 2026 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • R. Tyler McCabeExecutive Officer, Director
  • Tim S. GlassettExecutive Officer, Director
  • Stath J. KarrasDirector
  • Duck Joo LeeDirector
  • Troy E. MasonDirector
  • Ron E. NielsenDirector
  • Sheryl A. KingsbergDirector
  • Keith MarmerDirector
  • Stephanie SingerDirector
Offering amount
$2.8M
Amount sold
$1.7M
Minimum investment
$10K
Proceeds to insiders
$900K
First sale
Oct 2023
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50KraisedJun 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim S. GlassettExecutive Officer, Director
  • Ron NielsenDirector
  • Duck Joo LeeDirector
  • Troy E. MasonDirector
  • Stath J. KarrasDirector
  • Jayne F, CarneyDirector
  • R. Tyler McCabeExecutive Officer, Director
Offering amount
$1M
Amount sold
$50K
Minimum investment
$10K
Proceeds to insiders
$279K
First sale
Jun 2023
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$316.8KraisedNov 2022 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Stath J. KarrasDirector
  • Duck Joo LeeDirector
  • Tim S. GlassettExecutive Officer, Director
  • R. Tyler McCabeExecutive Officer, Director
  • Jayne F, CarneyDirector
  • Ron NielsenDirector
  • Troy E. MasonDirector
Offering amount
$1M
Amount sold
$316.8K
Minimum investment
$10K
Proceeds to insiders
$276K
First sale
Mar 2022
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$530KraisedMay 2021 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim S. GlassettDirector
  • Jayne F. CarneyDirector
  • Larry D. RigbyDirector
  • Duck Joo LeeDirector
  • R. Tyler McCabeExecutive Officer, Director
Offering amount
$600K
Amount sold
$530K
Minimum investment
$10K
Proceeds to insiders
$105K
First sale
Apr 2021
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$605KraisedJul 2020 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Duck Joo LeeDirector
  • Tim S. GlassettExecutive Officer, Director
  • R. Tyler McCabeExecutive Officer, Director
  • Jayne F. CarneyDirector
  • Larry D. RigbyDirector
Offering amount
$1M
Amount sold
$605K
Minimum investment
$10K
Proceeds to insiders
$138K
First sale
Jul 2020
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20KraisedDec 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • R. Tyler McCabeExecutive Officer, Director
  • Larry D. RigbyDirector
  • Tim S. GlassettDirector
  • Duck Joo LeeDirector
  • Jayne F. CarneyDirector
Offering amount
$500K
Amount sold
$20K
Minimum investment
$10K
Proceeds to insiders
$138K
First sale
Dec 2019
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.5KraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Larry D. RigbyDirector
  • Jayne F. CarneyDirector
  • R. Tyler McCabeExecutive Officer, Director
  • Tim S. GlassettDirector
  • Duck Joo LeeDirector
Offering amount
$600K
Amount sold
$22.5K
Minimum investment
$10K
Proceeds to insiders
$276K
First sale
Mar 2019
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$420KraisedDec 2018 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim S. GlassettDirector
  • R. Tyler McCabeExecutive Officer, Director
  • Duck Joo LeeDirector
  • Larry D. RigbyDirector
  • Jayne F. CarneyDirector
Offering amount
$900K
Amount sold
$420K
Minimum investment
$10K
Proceeds to insiders
$544K
First sale
Mar 2018
Incorporated
Corporation, Utah
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

J3 Bioscience Announces Collaboration to Study LIV-Ring VR101 for Cancer-Therapy–Related Vaginal Dryness — J3 Biosciencej3bio.com · Nov 2025Salt Lake City Utah based J3 Bioscience is raising $1,000,000.00 in New Debt Financing. - intelligence360intelligence360.news · Aug 2020

Frequently asked questions

What does J3 Bioscience do?
J3 Bio develops an FDA-cleared intravaginal ring platform called LivRing for delivering active and functional ingredients to address women's health needs across multiple conditions and life stages. The company targets the direct-to-consumer women's health market with clinically validated solutions designed for accessibility outside traditional medical channels.
Who founded J3 Bioscience?
J3 Bioscience was founded by DJ Lee.
How much funding has J3 Bioscience raised?
J3 Bioscience has disclosed $5.7M raised across 10 rounds.
Where is J3 Bioscience headquartered?
J3 Bioscience is headquartered in Salt Lake City, US.